These benefits, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the notion of concentrating on ACKR3 as a unique solution to modulate the opioid program, which could open up new therapeutic avenues for opio